Aric Coffman

“As we discuss our third quarter results, I want to begin by framing where we are in the evolution of the business. This continues to be a transitional year, one focused on improving stability, strengthening operating discipline and maturing the clinical foundation of the organization.”

“I'll begin with a few highlights from the quarter and by emphasizing that we are nearing full execution on the $130 million EBITDA improvement plan that we outlined during our previous calls.”

“The quarter was in line with our expectations. I'm going to cover the following topics in my remarks. First, our 2025 guidance; second, an update on our strategic initiatives that we announced on our Q3 2024 call; and third, a high-level view of our quarter.”

“Today, I'll cover several key topics: the broader Medicare Advantage landscape, our third quarter 2024 results, and why I'm excited for 2025. We'll go through the tangible steps we are taking to advance the initiatives we outlined in August, and this will set up P3 for success moving forward.”

“Let me start by expressing how thrilled I am to be at the helm of P3 as CEO from our first quarter. P3 Health Partners is a scaled capital-light platform comprising 2,900 primary care physicians in five states across 27 counties, and we are taking full risk at scale on 128,100 lives.”